BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

30 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
COMPOUNDS USED AS SRC INHIBITORSBDB
Wigen Biomedicine Technology (Shanghai) Co.
PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTAL FORM THEREOFBDB
Jiangsu Hengrui Pharmaceuticals
CRYSTAL FORM OF PYRROLOPYRIMIDINE COMPOUND AND PREPARATION METHOD FOR CRYSTAL FORMBDB
Zhejiang Longcharm Bio-Tech Pharma. Co.
Compounds and probes for imaging huntingtin proteinBDB
CHDI Foundation, Inc.
POTENT AND SELECTIVE COMPOUNDS AS SEROTONIN 1B RECEPTOR MODULATORSBDB
Leukos Biotech
Leucine-rich repeat kinase 2 (LRRK2) inhibitorsBDB
H. Lundbeck
PYRROLOPYRIDINE COMPOUND AND APPLICATION THEREOFBDB
Medshine Discovery
Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitorsBDB
Array Biopharma
OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERSBDB
Columbia University
GALECTIN-3 INHIBITING 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVESBDB
Idorsia Pharmaceuticals
Pyrazolopyridine Compounds and Methods of Inhibiting IRE1 Using SameBDB
Optikira
PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOFBDB
Biosplice Therapeutics
Thiadiazole IRAK4 inhibitorsBDB
Gilead Sciences
SSAO inhibitors and use thereofBDB
Eccogene (Shanghai)
Substituted pyrimidines, pharmaceutical compositions and therapeutic methods thereofBDB
Milstein Zhang & Wu
ATR inhibitor and application thereofBDB
Wuxi Biocity Biopharmaceutics
Dosage forms and regimens for amino acid compoundsBDB
Pliant Therapeutics
CaMKII inhibitors and uses thereofBDB
The Johns Hopkins University
Inhibitors of Bruton's tyrosine kinase and methods of their useBDB
Janssen Pharmaceutica
Oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitorsBDB
Merck Sharp & Dohme
Kinase inhibitors and uses thereofBDB
Denali Therapeutics
4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereofBDB
Shanghai Haiyan Pharmaceutical Technology
Cyano substituted heteroarylpyrimidinone derivative, preparation method and use thereofBDB
Zhejiang Hisun Pharmaceutical
Indoleamine-2,3-dioxygenase inhibitor and preparation method thereforBDB
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereofBDB
Guangzhou Maxinovel Pharmaceuticals
Chemical compoundsBDB
Astrazeneca
WDR5-MLL1 inhibitors and modulatorsBDB
Vanderbilt University
Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.BDB
Panjab University
VEGFR3 inhibitorsBDB
Cancer Therapeutics Crc Pty
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.BDB
Wichita State University